While dexamethasone, a commonly used corticosteroid, is a standard treatment for severe COVID-19, the study found that it modestly inhibited the release of arginase-1 from neutrophils. This was ...

The landscape of pandemic response has been transformed, with new standards being set for clinical excellence. A new report looks at emerging therapies, trial insights, and the innovations shaping the ...

Dexamethasone: The Game-Changer The first true success of drug repurposing in treating COVID-19 came with the discovery that ...

The severe acute respiratory syndrome coronavirus 2 just keeps doing what it does oh-so-well: it just keeps mutating and mutating and mutating, resulting in more and more variants. Leading the ...

[Wednesday, 18 December 2024] At the beginning of the COVID-19 pandemic, numerous studies had shown that COVID-19 patients with high levels of neutrophils, a key immune cell, presented with more ...

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.